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Deep sclerectomy (DS), one of the non-penetrating 
glaucoma surgeries, has been reported to be a safe and 
effective surgical procedure which provides long-term 
intraocular pressure (IOP) control in the management of 
open-angle glaucoma. Several studies comparing surgical 
outcomes of DS with those of trabeculectomy have also 
shown that DS provides less but comparable IOP reduc-
tion with fewer complications [1,2]. However, the surgical 
outcomes of DS may have racial differences. Although 
East Asian eyes are reported to ethnically differ in many 
aspects from other races, there are few reports about the 
long-term surgical results of DS in Asian populations. This 
report evaluates the long-term results of DS with small 
collagen implants in Korean open-angle glaucoma (OAG) 
patients.
Materials and Methods
After the approval of the institutional review board, 
65 subjects with planned deep sclerectomy with collagen 
implant (DSCI) with or without the adjunctive use of 
mitomycin C due to primary and secondary OAG were 
retrospectively collected. All subjects were Korean (single 
ethnic group).
All surgical procedures were performed by a single 
surgeon. A one-third scleral thickness, limbal-based, 5.0 
mm × 5.0 mm scleral flap was dissected. In the cases using 
mitomycin C, pieces of surgical sponge soaked with 0.2 
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Purpose: To describe the long-term results of deep sclerectomy with collagen implant (DSCI) with or without 
adjuvant mitomycin C in Korean patients with primary or secondary open-angle glaucoma (OAG).
Methods: This retrospective review was comprised of 65 Korean patients who received DSCI with or without 
adjuvant mitomycin C due to primary or secondary OAG. Patients were followed for 72 months after surgery. 
Complete success was defined as intraocular pressure (IOP) <21 mmHg without medication and qualified 
success was defined as IOP <21 mmHg with or without medication. 
Results: Mean postoperative follow-up period was 53.0 ± 16.2 months. Mean IOP was 30.5 ± 11.7 mmHg pre-
operatively, 8.4 ± 4.3 mmHg at postoperative day one and 13.4 ± 3.8 mmHg 60 months after surgery. The 
mean number of glaucoma medications was decreased from 3.6 ± 1.1 to 1.6 ± 1.3 at 60 months after the 
operation. Complete and qualified success rates were 36.7% and 79.6% at postoperative 60 months, respec-
tively (Kaplan-Meier survival curve). No shallow or flat anterior chamber, endophthalmitis, or surgery-induced 
significant cataract was observed. 
Conclusions: The results of DSCI in Korean patients presented here seem reasonably excellent with qualified 
success rates of over 70% at six years with negligible complications. 
Key Words:  Deep sclerectomy, Koreans, Open-angle glaucoma, Small collagen implant
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mg/mL mitomycin C were applied to the exposed sclera 
for three minutes and washed out with 10 mL saline irriga-
tion. In certain cases of thin conjunctiva (n = 4) or history 
of hypotony in the opposite eye (n = 2), mitomycin C was 
not applied. A hexahedron piece of deep sclera was then 
removed, leaving a thin scleral layer. Schlemm’s canal was 
de-roofed at the level of the scleral spur. The dissection 
was continued until the trabeculo-Descemet’s membrane 
(TDM) was exposed. The inner wall of Schlemm’s canal 
and the juxtacanalicular meshwork was peeled off. A 
synthetic absorbable collagen implant (Ultraplug; Surgi-
cal Specialties, Reading, PA, USA) of a cylindrical shape 
measuring 0.4 mm in diameter and 2.0 mm in length was 
placed in the center of the deep sclerectomy and sutured 
with 10-0 nylon. The superficial scleral f lap was reposi-
tioned over the implant and sutured with 10-0 nylon. 
Surgery was considered a complete success when IOP 
was less than 21 mmHg without anti-glaucoma medica-
tion or laser goniopuncture, and a qualified success when 
medication or laser goniopuncture was necessary. It was 
considered a failure when an eye required further drain-
age surgery or lost light perception. Goniopuncture with a 
neodymium:YAG laser was performed when IOP failed to 
remain below 21 mmHg due to TDM fibrosis.
Kaplan-Meier survival curves were constructed using 
PASW ver. 18.0 (SPSS Inc., Chicago, IL, USA) for long-
term success rate analysis.
Results
Patient demographics are shown in Table 1. Of the 65 
eyes initially selected for the initial review, 16 eyes were 
excluded from further analysis due to follow-up periods 
less than 12 months.
The IOP and best-corrected visual acuity changes are 
shown in Figs. 1 and 2. The mean IOP was 30.5 ± 11.7 
mmHg (49 patients) preoperatively and 8.4 ± 4.3 mmHg 
one day postoperatively. However, as length out from 
surgery increased, the mean IOP was slightly increased 
to 13.2 ± 3.7 mmHg (25 patients) at 48 months and to 13.4 
± 3.8 mmHg (16 patients) at 60 months postoperatively. 
Complete success was 59.2% at 12 months but decreased 
to 36.7% at 60 months. Qualified success registered at 
89.9% at 12 months and 79.6% at 60 months (Fig. 3). When 
we change the definition of success to an IOP level of 18 
mmHg, complete and qualified success rates were slightly 
decreased to 34.7% and 75.5% 60 months postoperatively, 
respectively. The mean number of anti-glaucoma medica-
tions decreased from 3.6 ± 1.1 (49 patients) to 0.8 ± 1.4 (25 
patients) at 48 months, then increased to 1.6 ± 1.3 (16 pa-
tients) at 60 months postoperatively (Fig. 4). 
No shallow or f lat anterior chamber, endophthalmitis, 
or surgery-induced significant cataract was observed. 
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Fig. 1. Intraocular pressure (IOP) results during follow period 
(mean ± SD). Preop = preoperative.
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Fig. 2. Visual acuity results during follow period (mean ± SD). 
Preop = preoperative.
Table 1. Subject characteristics
Characteristic Value
Gender (M : F) 29 : 20 
Laterality (R : L) 22 : 27 
Age (yr) 43.1 ± 17.0 
Diagnosis (n) Primary open-angle 
glaucoma 
19 
Uveitic glaucoma 21 
Steroid-induced glaucoma 7 
Traumatic glaucoma 2 
Use of mitomycin-C       43 (87.8%) 
Postoperative follow-up duration (mon) 53.0 ± 16.2 
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However, five eyes (10.2%) developed a progression of 
pre-existing cataract. Four eyes (8.2%) showed chronic hy-
potony lasting for more than two months. Goniopuncture 
was performed in 23 eyes (46.9%). Mean time between 
DSCI and goniopuncture was 4.7 ± 6.1 months. The rate 
of iris synechiae formation after laser goniopuncture was 
5.4%. When the TDM was perforated, the procedure was 
converted to and completed as trabeculectomy. The con-
version rate to trabeculectomy plateaued below 20% (Fig. 
5).
Discussion
Non-penetrating glaucoma surgery is technically more 
difficult to perform than conventional trabeculectomy, as 
it requires a longer learning curve [3-5]. Our experience 
shows a similar declining conversion rate as providers be-
come more accustomed to the procedure. 
The efficacy of IOP reduction after DSCI when com-
pared to conventional trabeculectomy has been an issue 
[6,7] (Table 2). Shaarawy et al. [5] reported a higher suc-
cess rate of DSCI compared to DS only [8]. In terms of not 
only success rate but also the number of anti-glaucoma 
medication after surgery, their report showed relatively 
desirable results. Lachkar et al. also described similar long 
term outcome (six years) of DS retrospectively. Chiselita 
found a small but statistically significant lower IOP in the 
trabeculectomy group, but had fewer complications in the 
DSCI group. It is obvious that we cannot directly compare 
the outcome of respective studies. However, many reports 
show that DSCI is better than DS only by means of success 
rate [9,10].
DSCI has non-penetrating characteristic though, in that 
it cannot be completely free from the nature of filtering 
surgery. Xu et al. [11] demonstrated the physiology of DS 
with porcine eyes. The major factors affecting postopera-
tive outflow increase include the subconjunctival pathway, 
the functional deep scleral lake and the opening of Sch-
lemm’s canal.
In the past few years, it was discovered by authorities 
that the major late complication of DSCI was the loss of its 
efficacy [12]. This study found that 46% of eyes eventually 
needed goniopuncture at a mean post-operative period of 
4.7 ± 6.1 months. It has been speculated that an early (less 
than nine months after the initial procedure) necessity for 
goniopuncture was because of the lack of surgical dissec-
tion during the initial procedure and when the necessity 
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Fig. 4. Number of antiglaucoma medications before and after 
deep sclerectomy. Preop = preoperative.
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Fig. 5. Rate of conversion to other glaucoma surgery over time.
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arose late in the course of follow-up, it was probably due to 
fibrosis of the TDM [5].
This differs from the findings of the present study. Most 
eyes requiring goniopuncture showed good filtration and 
low IOPs immediately after the initial DSCI procedure. 
We believe that this study group, as a single ethnic group, 
may show differences in patterns of postoperative fibrosis. 
This ethnic characteristic is also evident in the rate of iris 
synechiae formation after laser goniopuncture. The present 
study shows a significantly higher rate of synechiae forma-
tion at 5.4% that needed reduction by laser synechiolysis 
and peripheral iridectomy compared to a previous report 
[13]. The authors presume an ethnic predisposition to in-
flammation leading to excessive fibrosis after laser proce-
dures involving uveal tissue in Koreans. Mermoud et al. [14] 
described the immediate success rate of goniopuncture as 
83% with no iris synechiae. In fact, it is not always clear 
whether the iris synechiae was developed by the laser 
goniopuncture or by the surgery (DS) itself. For example, 
Moreno-Montanes et al. [15] reported that nine eyes (8.49%, 
total 106 eyes) showed iris synechiae after DS only. 
Shallower anterior chambers and more reaction to light 
may also affect postoperative results. According to the 
study by Oh et al. [16], no statistically significant differ-
ence was found between the angle width of African-Amer-
icans, Caucasians and Far East Asians, however, the iris 
attaches to the scleral wall more anteriorly in Asian popu-
lations. Wang et al. [17] noted that Chinese populations had 
a smaller angle recess area and trabecular-iris space area, 
but greater dark-to-light changes in angle opening distance 
and the trabecular-iris space area. The answer warrants 
future study, which may possibly involve anterior chamber 
depth measurements.
Other possible reasons for the lower success rate include 
higher preoperative IOP level and a much greater number 
of preoperative glaucoma medications (Table 2). It has 
already been known that the eye of the patient who has 
higher IOP at diagnosis shows a lower success rate of tra-
beculectomy [18,19]. Additionally, those using two or more 
topical medications were more at risk of failure [18]. These 
might be applicable to predict outcome of DSCI. Moreover, 
the different proportion of uveitic glaucoma, which has a 
relatively poor outcome, could influence the lower success 
rate [18].
In conclusion, these results show that DSCI in Korean 
glaucoma patients can have a relatively lower complete 
success rate and tolerable qualified success rate compared 
to the outcome of other previous studies. The structural 
difference in anterior segment (in relation to ethnicity), 
higher preoperative IOP level, and increased number of 
preoperative anti-glaucoma eyedrops are the possible fac-
tors leading to a lower success rate.
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